Updated Jul 16, 2026
Kearns Evan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $2.52M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-30 | COGT | Cogent Biosciences, Inc. | S — Open-market sale | 65.0K | $38.70 | $2.52M |
| 2025-12-19 | COGT | Cogent Biosciences, Inc. | F — Tax withholding / forfeiture | 125.6K | $39.45 | $4.95M |
| 2025-12-19 | COGT | Cogent Biosciences, Inc. | A — Grant or award | 260.0K | $0.00 | |
| 2025-12-19 | COGT | Cogent Biosciences, Inc. | A — Grant or award | 40.0K | $0.00 |
Kearns Evan is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($2.52M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kearns Evan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.